Back to Search Start Over

Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial

Authors :
Arina J ten Cate-Hoek
Elham E Amin
Annemieke C Bouman
Karina Meijer
Lidwine W Tick
Saskia Middeldorp
Guy J M Mostard
Marije ten Wolde
Simone M van den Heiligenberg
Sanne van Wissen
Marlène HW van de Poel
Sabina Villalta
Erik H Serné
Hans-Martin Otten
Edith H Klappe
Ingrid M Bistervels
Mandy N Lauw
Margriet Piersma-Wichers
Paolo Prandoni
Manuela A Joore
Martin H Prins
Hugo ten Cate
Martin R Nijziel
Mandy Lauw
Y Whitney Cheung
Marlène H W van de Poel
Valentina Vedovetto
Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
Internal medicine
ACS - Diabetes & metabolism
ACS - Microcirculation
RS: CARIM - R1.04 - Clinical thrombosis and haemostasis
Biochemie
MUMC+: HVC Pieken Trombose (9)
Interne Geneeskunde
RS: CAPHRI - R2 - Creating Value-Based Health Care
Health Services Research
MUMC+: KIO Kemta (9)
RS: CAPHRI - R5 - Optimising Patient Care
Epidemiologie
MUMC+: MA Alg Interne Geneeskunde (9)
ARD - Amsterdam Reproduction and Development
Vascular Medicine
ACS - Amsterdam Cardiovascular Sciences
Other departments
ACS - Pulmonary hypertension & thrombosis
Source :
ten Cate-Hoek, A J, Amin, E E, Bouman, A C, Meijer, K, Tick, L W, Middeldorp, S, Mostard, G J M, ten Wolde, M, van den Heiligenberg, S M, van Wissen, S, van de Poel, M H W, Villalta, S, Serné, E H, Otten, H M, Klappe, E H, Bistervels, I M, Lauw, M N, Piersma-Wichers, M, Prandoni, P, Joore, M A, Prins, M H & ten Cate, H 2018, ' Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT) : A multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial ', The Lancet Haematology, vol. 5, no. 1, pp. e25-e33 . https://doi.org/10.1016/S2352-3026(17)30227-2, Lancet Haematology, 5(1), 25-33. ELSEVIER SCI LTD, The Lancet Haematology, 5(1), e25-e33. Lancet Publishing Group, Lancet Haematology, 5, 1, pp. 25-33, The Lancet Haematology, 5(1), 25-33. ELSEVIER SCI LTD, Lancet. Haematology, 5(1), e25-e33. Lancet Publishing Group, Lancet Haematology, 5, 25-33
Publication Year :
2018

Abstract

Background: Therapy with elastic compression stockings has been the cornerstone for prevention of post-thrombotic syndrome for decades in patients after acute deep venous thrombosis. It is uncertain who benefits most from therapy, and what the optimum duration of therapy should be. We therefore aimed to assess the safety and efficacy of individualised duration of compression therapy versus the standard duration of 24 months following an initial treatment period of 6 months. Methods: We did a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial at 12 hospitals in the Netherlands and two in Italy. We randomly assigned patients (1:1) with acute proximal deep vein thrombosis of the leg and without pre-existent venous insufficiency (Clinical Etiological Anatomical and Pathophysiological score

Details

Language :
English
ISSN :
23523026
Volume :
5
Issue :
1
Database :
OpenAIRE
Journal :
Lancet. Haematology
Accession number :
edsair.doi.dedup.....20e61c2ee20b248472af435872ddaf74
Full Text :
https://doi.org/10.1016/s2352-3026(17)30227-2